INTECH Investment Management’s Evolent Health EVH Stock Holding History

INTECH Investment Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$127K	Sell	23,483 -6,638	-22%	-$25.4K	﹤0.01%	1904
2026 Q1	$68.7K	Sell	30,121 -29,919	-50%	-$94.9K	﹤0.01%	1965
2025 Q4	$240K	Buy	60,040 +5,876	+11%	+$32.7K	﹤0.01%	1876
2025 Q3	$458K	Buy	54,164 +640	+1%	+$6.21K	﹤0.01%	1622
2025 Q2	$603K	Sell	53,524 -3,641	-6%	-$33.4K	0.01%	1493
2025 Q1	$541K	Buy	57,165 +7,164	+14%	+$72.4K	0.01%	1569
2024 Q4	$563K	Buy	50,001 +15,026	+43%	+$264K	0.01%	1494
2024 Q3	$989K	Buy	+34,975	New	+$901K	0.01%	809

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

INTECH Investment Management's EVH Position: Q2 2026 in Review

INTECH Investment Management reduced its Evolent Health (EVH) stake by 22% in Q2 2026, selling an estimated $25.4K and leaving 23,483 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #1904.

INTECH Investment Management first reported a position in EVH in Q3 2024 and has held it in 8 quarters since. The position peaked at $989K in Q3 2024. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

INTECH Investment Management held 23,483 shares of Evolent Health worth $127K as of Q2 2026.
INTECH Investment Management sold 6,638 Evolent Health shares in Q2 2026, an estimated $25.4K.
Evolent Health made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1904 holding.
INTECH Investment Management first reported a position in Evolent Health in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Evolent Health position peaked at $989K in Q3 2024.
198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.